Diagnosis and Outcomes of Placental Accretism
1 other identifier
observational
70
1 country
7
Brief Summary
The goal of this observational study is to evaluate the diagnostic ability of the main criteria currently adopted for the diagnosis of placenta accreta and to define the maternal outcomes in terms of complications of the different management strategies currently adoptable when placental accretism is suspected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2023
Typical duration for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2023
CompletedFirst Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 19, 2025
October 1, 2024
3.5 years
December 3, 2024
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of correspondence between prenatal diagnosis and intra-operative finding of placental accretism
disappearance of the hypoecogenaretroplacental stria, lacunae placental vasculature, hypervascularization of the utero-vesical interface, interruption/irregularity of the bladder will be assessed by ultrasound
Up to 1 month post-partum
Secondary Outcomes (1)
Frequency of maternal complications (Surgical site infection)
Up to 1 month post-partum
Eligibility Criteria
Patients with suspected placental accretism/percretism followed at the Outpatient Clinics of the Division of Obstetrics and Prenatal Age Medicine at IRCCS-AOUBO Policlinico di Sant'Orsola and participating centers.
You may qualify if:
- Age between 18 years and 44 years
- Pregnant women with suspected placental accretism
- Acquisition of informed consent form
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
Ospedale "M. Bufalini"
Cesena, Forlì-Cesena, 47521, Italy
Ospedale "Morgagni-Pierantoni"
Forlì, Forlì-Cesena, 47121, Italy
AOU Policlinico di Modena
Modena, Modena, 41100, Italy
Azienda Ospedaliero - Universitaria di Parma
Parma, Parma, 43126, Italy
Arcispedale Santa Maria Nuova
Reggio Emilia, Reggio Emilia, 42123, Italy
Ospedale "Infermi" di Rimini
Rimini, Rimini, 47900, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianluigi Pilu, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2024
First Posted
February 19, 2025
Study Start
July 17, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 19, 2025
Record last verified: 2024-10